Healthcare IT Today November 6, 2020
Guest Author

The following is a guest article by Haim Neerman, CEO at Variantyx.

As a society, how much should be invested in creating a “transformative textbook of medicine, with insights that will give health care providers immense new power to treat, prevent and cure disease”?

In this case, it is a trick question. The investment has already been made. Thirteen years and billions of dollars later the apt description of the return on investment you just read was provided in 2001 by Francis Collins, then director of the National Human Genome Research Institute. The Human Genome Project has also been described it as “one of the great feats of exploration in history” which “gave us the ability, for the first time,...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Patient / Consumer, Pharma / Biotech, Precision Medicine, Provider
Exploring the potential of personalized precision medicine for healthcare industry
Putting Patients First by Extending the Reach of World-Class Care
Healthcare's most promising tech
AI In Healthcare: A New Era Of Personalized Patient Care
23andMe reports sales decline a day after announcing plans to cut 40% of workforce

Share This Article